ESSA Pharma Inc.
EPIX
$1.74
$0.021.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.56% | -7.37% | -0.89% | 4.21% | 21.20% |
| Total Depreciation and Amortization | -17.93% | -23.40% | -21.79% | -15.46% | -8.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 168.31% | 41.71% | -21.49% | -52.43% | -52.38% |
| Change in Net Operating Assets | -41.06% | -117.90% | 42.53% | 203.86% | 173.12% |
| Cash from Operations | -0.94% | -14.83% | -4.69% | 4.89% | 16.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,184.41% | 2,702.40% | 1,166.50% | 490.95% | 114.24% |
| Cash from Investing | 1,184.41% | 2,702.40% | 1,166.50% | 490.95% | 114.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 76.96% | 51.16% | 24.96% |
| Issuance of Common Stock | 238.87% | 1,247.31% | 1,658.05% | 855.17% | -29.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 545.04% | 1,461.18% | 1,057.64% | 1,727.98% | -33.18% |
| Foreign Exchange rate Adjustments | 171.88% | 279.17% | -93.90% | -95.03% | -96.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 465.12% | 399.50% | 261.62% | 212.99% | 77.27% |